$HQY

DILLON ADRIAN T sold $798K of HQY

DILLON ADRIAN T sold 7,632 shares of HEALTHEQUITY, INC. (HQY) at an average of $104.61 ($104.47–$105.26, $0.80M total) across 2 trades on 2026-08-25 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DILLON ADRIAN T
Published Aug 27, 2026, 9:04 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 27, 2026, 9:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$HQY
Bearish
medium confidence
Mentioned
$HQY
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HQYBearishLow
01

Why it matters

The director's sale may be interpreted as a bearish signal, but the pre‑arranged 10b5‑1 plan reduces the informational value.

02

Market read

Primary disclosure of a sizable insider sale; modest relevance for traders monitoring insider activity.

03

What to watch

Potential tax planning or portfolio rebalancing unrelated to company outlook.

Relevance 4/10Novelty 7/10Timing: filed today

Background

Healthequity is a publicly traded health‑technology platform. Insider transactions are disclosed via Form 4.

Company-level read

Ticker impact

$HQYBearishMedium confidence
Context

Director Dillon Adrian T sold 7,632 shares of Healthequity for $798,373 via a 10b5-1 plan.

Expected impact

modest short-term downside pressure

Evidence & confidence

The sale size (~$800k) is material for a mid‑cap, but no other catalyst is present.

Market effects

Limited; reflects insider activity in the health‑tech sector.

None

None

Counterpoint

The sale could be routine under a pre‑arranged plan, not a negative signal.

Key entities

  • Healthequity, Inc.

    Issuer of the shares sold.

  • Dillon Adrian T

    Director and reporting insider.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HQYHighAI 8/10

HealthEquity (HQY) Q2 2027 Earnings Call Transcript

HealthEquity (HQY) reported Q2 2027 revenue of $350.7M, up 8% YoY, and adjusted EBITDA of $167M, up 11%. HSA assets grew 14% to $37.9B. The company raised full-year revenue guidance to $1.411B-$1.421B and adjusted EBITDA to $628M-$636M. Management highlighted growth in custodial and service revenue, as well as operational efficiencies from AI and technology investments.

$HQYMed

Why HealthEquity Stock Sank This Week

HealthEquity (HQY) stock fell 8.6% this week despite beating earnings and revenue estimates for Q2. The company reported adjusted EPS of $1.24 on revenue of $350.7M, up 15.7% and 7.6% YoY, respectively. Investors expected stronger guidance, as the company only slightly raised its full-year revenue target and reiterated EPS guidance.